Greenberg dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1426OMIM:215140Q77.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Greenberg dysplasia, also known as hydrops-ectopic calcification-moth-eaten (HEM) skeletal dysplasia, is an extremely rare and lethal autosomal recessive skeletal disorder. It is caused by mutations in the LBR (lamin B receptor) gene, which encodes an enzyme involved in cholesterol biosynthesis (sterol-14-reductase). The disease is characterized by severe fetal hydrops (abnormal fluid accumulation in multiple body compartments), markedly disorganized skeletal development, and a distinctive "moth-eaten" radiographic appearance of the long bones due to ectopic calcification within cartilage. Other key features include severe shortening of the limbs (micromelia), platyspondyly (flattened vertebral bodies), and disorganized chondro-osseous development. Greenberg dysplasia presents prenatally and is invariably lethal, with affected fetuses typically dying in the second or third trimester of pregnancy or at birth. The condition affects the skeletal system profoundly, with abnormal endochondral ossification and widespread ectopic calcifications throughout the skeleton. Severe non-immune hydrops fetalis is a hallmark finding. The radiographic moth-eaten pattern of bones is a distinctive diagnostic feature that helps differentiate this condition from other lethal skeletal dysplasias. There is no treatment or cure for Greenberg dysplasia due to its uniformly lethal nature. Management is limited to supportive care and genetic counseling for affected families. Prenatal diagnosis may be possible through ultrasound findings of hydrops and skeletal abnormalities, and can be confirmed by molecular genetic testing of the LBR gene. Carrier testing and prenatal molecular diagnosis are available for families with a known pathogenic variant. Fewer than 30 cases have been reported in the medical literature.

Also known as:

Clinical phenotype terms— hover any for plain English:

Calvarial skull defectHP:0001362Abnormal leukocyte morphologyHP:0001881Decreased skull ossificationHP:0004331Anterior rib punctate calcificationsHP:0006619Severe short-limb dwarfismHP:0008890Abnormal pelvis bone ossificationHP:0009106Abnormal bone ossificationHP:0011849Abnormally ossified vertebraeHP:0100569PreeclampsiaHP:0100602
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Greenberg dysplasia.

View clinical trials →

No actively recruiting trials found for Greenberg dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Greenberg dysplasia community →

Specialists

1 foundView all specialists →
FM
Forbes D Porter, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 14 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Greenberg dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Greenberg dysplasiaForum →

No community posts yet. Be the first to share your experience with Greenberg dysplasia.

Start the conversation →

Latest news about Greenberg dysplasia

No recent news articles for Greenberg dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Greenberg dysplasia

What is Greenberg dysplasia?

Greenberg dysplasia, also known as hydrops-ectopic calcification-moth-eaten (HEM) skeletal dysplasia, is an extremely rare and lethal autosomal recessive skeletal disorder. It is caused by mutations in the LBR (lamin B receptor) gene, which encodes an enzyme involved in cholesterol biosynthesis (sterol-14-reductase). The disease is characterized by severe fetal hydrops (abnormal fluid accumulation in multiple body compartments), markedly disorganized skeletal development, and a distinctive "moth-eaten" radiographic appearance of the long bones due to ectopic calcification within cartilage. Oth

How is Greenberg dysplasia inherited?

Greenberg dysplasia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Greenberg dysplasia typically begin?

Typical onset of Greenberg dysplasia is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Greenberg dysplasia?

1 specialists and care centers treating Greenberg dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.